There are 2934 resources available
Biological rationale for treating the primary tumour
Presenter: Charles Swanton
Session: Treatment of the primary tumour in the metastatic setting
Resources:
Slides
Webcast
The radiation perspective: Bladder carcinoma model
Presenter: Nicholas James
Session: Treatment of the primary tumour in the metastatic setting
Resources:
Slides
Webcast
The medical oncologist perspective
Presenter: Andrea Necchi
Session: Treatment of the primary tumour in the metastatic setting
Resources:
Slides
Webcast
The urologist perspective: The RCC model
Presenter: Axel Bex
Session: Treatment of the primary tumour in the metastatic setting
Resources:
Slides
Webcast
Responsibilities of the physician
Presenter: Scott Berry
Session: Bedside rationing: To prescribe or not to prescribe?
Resources:
Slides
Webcast
Responsibilities of the health economist
Presenter: Guillem Lopez Casasnovas
Session: Bedside rationing: To prescribe or not to prescribe?
Resources:
Slides
Webcast
View of an expert in bioethics
Presenter: Jan Helge Solbakk
Session: Bedside rationing: To prescribe or not to prescribe?
Resources:
Slides
Webcast
5576 - Genomic characteristics and predicted ancestry of NTRK1/2/3 and ROS1 fusion-positive tumors from >165,000 pan-solid tumors
Presenter: Timothy R Wilson
Session: Poster Discussion – Developmental therapeutics
Resources:
Abstract
4536 - Safety and preliminary clinical activity of repotrectinib in patients with advanced ROS1/TRK fusion-positive solid tumors (TRIDENT-1 study)
Presenter: Alexander Drilon
Session: Poster Discussion – Developmental therapeutics
Resources:
Abstract
5684 - Durability of response with larotrectinib in adult and pediatric patients with TRK fusion cancer
Presenter: David Hyman
Session: Poster Discussion – Developmental therapeutics
Resources:
Abstract